Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    16531616 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Optimal Anti-platelet Treatment for Patients With Clopidogrel Low Response
Condition: Coronary Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel;   Drug: Cilostazol
2 Recruiting Pharmacodynamic Study on Efficacy of Clopidogrel With St. John's Wort
Condition: Acute Coronary Syndrome
Interventions: Drug: Placebo;   Drug: St. Johns Wort
3 Completed Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
Condition: Arteriosclerosis
Intervention: Drug: clopidogrel (SR25990)

Indicates status has not been verified in more than two years